Language:
KNOWLEDGE & RESOURCES
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
- The Right (Legal Standing) To Claim Nullity of a Pharma Patent.Author:Armando Arenas Nov-01-2024
- Chambers Latín América 2024- Mexico: Life Science.Authors: Alejandro Luna F. & Luz Elena Elias Consequences of a Lack of a Proper Linkage System in Mexico Aug-29-2024
- Legal 500 Country Comparative Guides 2024 Authors: Alejandro Luna F, Ingrid Ortiz, Alexis Damian & Juan E. Figueroa Aug-14-2024
- ICLG – Pharmaceutical Advertising 2024. Authors: Ingrid Ortiz & Luz Elena Elías Aug-08-2024
- Mexico: regulatory certainty for biosimilars on the horizon. Authors: Alejandro Luna F. & Ingrid OrtizThe Guide to Life Sciences: Key issues for senior life sciences executives Jul-16-2024
- The Pharma Legal Handbook: Mexico 2023. Authors: Alejandro Luna F. & Ingrid OrtizThe Pharma Legal Handbook answers essential questions about this environment for pharmaceuticals in Mexico. It is a must have for any company operating in the country or looking to enter the market. Feb-14-2024
- Life Sciences Commercialisation in Mexico: Overview. Authors: Alejandro Luna F., Armando Arenas & Karla P. Olvera A Q&A guide to life sciences commercialisation in Mexico. Nov-29-2023
- Life Sciences Regulation in Mexico: Overview. Authors: Alejandro Luna F., Armando Arenas & Karla P. Olvera A Q&A guide to life sciences regulation in Mexico. Nov-29-2023
- Lexology GTDT – Pharma & Medical Device Regulation 2024 – Mexico. Authors: Ingrid Ortiz & Jorge Juarez Oct-27-2023
- Mexico’s patent linkage system and allopathic medicines. Authors: Alejandro Luna F. & Ingrid Ortiz Oct-13-2023
- Lexology GTDT Healthcare Regulation 2024 – Mexico.
Authors: Alejandro Luna F., y Luz Elena Elias.Sep-28-2023 - Lexology GTDT Healthcare Enforcement & Litigation 2023 – Mexico.
Authors: Alejandro Luna F., Armando Arenas & Karla Olvera.Aug-31-2023 - ICLG – Pharmaceutical Advertising 2023.
Authors: Ingrid Ortíz & Luz Elena Elías.Jul-14-2022 - Issues with the patent linkage system in Mexico.
Jul- 11 -2022 - Measures Needed to Counter Entry of Unauthorized Medicines.
Author: Armando Arenas.May- 25 -2022 - Lexology GTDT – Life Sciences 2023 – Mexico
Authors: Alejandro Luna F. & Ingrid OrtizDec- 13 -2022 - Lexology GTDT – Pharmaceutical Trademarks (WTR) 2023 – Mexico
Authors: Abraham Díaz & Karla OlveraDec- 08 -2022 - An Academic View of Compulsory Licenses and Alternatives
Authors: Alejandro Luna F. & Moises CastorenaDec- 07 -2022 - Lexology GTDT – Pharma & Medical Device Regulation 2023 – Mexico
Authors: Ingrid Ortiz & Luz Elena ElíasNov- 06 -2022 - The Pharma Legal Handbook Mexico – 2022.
Authors: Alejandro Luna F. & Ingrid OrtizAug- 31 -2022 - Lexology GTDT Healthcare Enforcement & Litigation 2023.
Authors: Alejandro Luna F., Armando Arenas & Karla OlveraAug- 26 -2022 - IAM Life Sciences 2022 – Legal and strategic questions surrounding biologic and biosimilar litigation.
Authors: Karla Olvera & Ingrid OrtízAug- 25 -2022 - Patent Term Compensation for the Life Sciences.
Authors: Alejandro Luna F.Jul- 29 -2022 - ICLG Pharmaceutical Advertising 2022 – Mexico.
Authors: Alejandro Luna F. & Armando ArenasMay- 25 -2022 - ICLG Digital Health 2022 – Mexico.
F- 03 -2022 - Answers essential questions about this environment for pharmaceuticals in Mexico.
Authors: Alejandro Luna F. & Ingrid Ortíz
The Pharma Legal Handbook answers essential questions about the environment for pharmaceuticals in Mexico. It is a must have for any company operating in the country or looking to enter the market.
Jan- 18 -2022 - Patent waiving Is not the solution to enhance access.
Jan- 17 -2022 - Health & Patent Rights During the COVID-19 Pandemic.
Jan- 05 -2022 - Lexology GTDT – Pharma & Medical Device Regulation 2022 – Mexico.
Jan- 03 -2022 - Lexology GTDT – Life Sciences 2022 – Mexico.
Jan- 03 -2022 - Lexology GTDT Healthcare Enforcement & Litigation 2022 – Mexico.
Jul- 05 -2021 - Health & Patent Rights During the COVID-19 Pandemic.
Jul- 05 -2021 - Commercialisation of Healthcare in Mexico: Overview.
Jun- 29 -2021 - ICLG – Pharmaceutical Advertising 2021.
Jun- 29 -2021 - Pharma Board Room – Legal & Regulatory – Mexico – Health & Patent Rights During the COVID-19 Pandemic.
Jun- 11 -2021 - Pharmaceutical IP and competition law in Mexico: overview.
Jun- 01 -2021 - Medicinal producto regulation and producto liability in Mexico: overview.
Jun- 01 -2021 - Life Sciences Global Guide Mexico – Pharmaceutilcal IP and competition law in Mexico: overview.
May- 13 -2021 - Life Sciences Global Guide Mexico – Medicinal product regulation and product liability en Mexico: overvew.
May- 13 -2021 - Mexico Business.news Health Do New Medicine Procurement Rules Violate Constitution?
Apr- 13 -2021 - ICLG – Digital Health 2021: Digital Health and Health Care IT
Mar- 05 -2021 - A debated shortcut for import permits of foreign pharmaceutical products in Mexico
Mar- 05 -2021 - Lexology GTDT Healthcare Enforcement & Litigation 2021 – MexicoJan -06-2021
- Lexology GTDT – Life Sciences 2021 – MexicoJan -06-2021
- Lexology GTDT Agribusiness 2021 – MexicoJan -06-2021
- Lexology GTDT – Pharmaceutical Trademarks 2021 – MexicoDic -17-2020
- A debated shortcut for import permits of foreign pharmaceutical products in Mexico
Dec- 02 -2020 - Lexology GTDT – Pharma & Medical Device Regulation 2021 – Mexico
Oct- 12 -2020 - Second-Use Patents and the New Mexican IP Law
Sep- 23 -2020 - USMCA Entry Demands Amendments to Mexican Regulations
Ago- 18 -2020 - ICLG Pharmaceutical Advertising 2020
Jun -08 -2020 - Regulatory framework-healthcare products and Intellectual Property in Mexico. IAM 2020
May -29 -2020 - The Life Sciences Lawyer. COVID-19: The invisible enemy revisited.
May -22 -2020 - Exceptional Measures for Exceptional Times.
May -12 -2020 - ICLG Digital Health 2020
Mar -11 -2020 - Lexology GTDT Pharma & Medical Device Regulation 2020
Feb -13 -2020 - Regulating cannabis use in Mexico – current legal framework
Dec -06 -2019 - Healt Services Framework And Competent Authorities
Nov -13 -2019 - Pharma & Medical Device Regulation 2020 – Mexico
Nov -11 -2019 - Pharmaceutical IP and competition law in Mexico: overview
Sep -03 -2019 - Medicinal product regulation and product liability in Mexico: overview
Sep -03 -2019 - Commercialisation of healthcare in Mexico: overview
Aug -29 -2019 - WTR Pharmaceutical Trademark Guide 2020
Aug -27 -2019 - 2020 Edition of Healthcare Enforcement & Litigation Mexico
Aug -06 -2019 - ICLG Pharmaceutical Advertising 2019
Jul -09 -2019 - ICLG Pharmaceutical Advertising 2019
Jun -21 -2019 - GTDT Healthcare Enforcement & Litigation 2019
Nov -20 -2018 - IAM Life Sciences
May -31 -2018 - The International Comparative Legal Guide to Pharmaceutical Advertising 2018 Edition – Mexico
May – 15 – 2018 - Product regulation and liability in Mexico
Apr – 18 – 2018 - Impact of the “Comprehensive and Progressive Agreement for Trans-Pacific Partnership” on Life Sciences in Mexico
Mar – 28 – 2018 - Pharmaceutical Trademarks: A Global Guide 2018/2019
Mar – 27 -2018 - Mexico Commercialisation of Healthcare
Feb – 20 2018 - Life Sciences IP Review Bio 2017 edition
Jan – 25 -2018 - Practical Law’s Commercialisation of Healthcare Global Guide
Jan – 25 -2018 - Pharma 2018-2019
Jan – 2018 - Getting the Deal Through – Life Sciences
Jan – 2018 - Legal Q&A – Pharma Boardroom
Jan – 2018 - Pharmaceutical IP and competition law in Mexico: overview
Aug-16-2017 - IP rights protection and enforcement strategies for plant innovations in Mexico
Aug-15-2017 - Commercialisation of Healthcare in Mexico: Overview
Aug-15-2017 - Life Sciences – Product regulation and liability in Mexico
Jun-14-2017 - ICLG Pharmaceutical Advertising 2017
May-30-2017 - Medicinal product regulation and product liability in Mexico: overview May 2017
May-15-2017 - Pharma Boardroom Interview
Apr-03-2017 - Cannabis and Narcotics for Medicinal use in Mexico
Mar-08-2017 - ICLG to: Pharmaceutical Advertising 2016
Jun-22-2016 - Chapter 18 of TPP hits the Mexican life sciences industry
May-26-2016 - Medicinal product regulation and product liability in Mexico: overview
Mar-03-2016 - Chapter 18 of the TPP hits the life science industry in Mexico
Feb-11-2016 - Getting the Deal Through – Life Sciences 2016
Nov-03-2015 - Latest developments in biologics and biosimiliar regulation
Oct-23-2015 - Data protection exclusivity for biologics
Oct-08-2015 - ICLG Pharma Advertising 2015
Jun-22-2015 - Tightening the Customs Net
Jun-22-2015 - Key issues for biotech products in mexico
Jun-08-2015 - Pharmaceutical Law and Intellectual Property in Latin America
Apr-06-2015 - Pharmaceutical Trademark Guide – Mexico 2015
Feb-17-2015 - Getting the Deal Through – Life Science 2015
Feb-17-2015 - Life Sciences – Multi-jurisdictional Guide 2013: Mexico
Feb-17-2015 - Life Sciences – Multi-jurisdictional Guide 2014: Mexico
Feb-17-2015 - Getting the Deal Through – Life Sciences 2014
Aug-25-2014 - APIs, imports and the Bolar exemption: concerns and practical measures
Feb-04-2014 - Current Conditions of Use Claims in the Pharmaceutical Sector in Mexico
Apr-01-2013 - Crossed wires: protecting medicines in Mexico
Apr-01-2013 - Life Sciences – Multi-jurisdictional Guide 2012: Mexico
Jun-20-2012 - Maximising IP rights in the life sciences industry
Jun-08-2012 - Latin America Roundtable
Sep-13-2011 - New regulations pending
Sep-12-2011 - The International Comparative Legal Guide to: Patents 2012
Sep-06-2011 - Approval of follow-on biologics in Mexico
Jun-02-2011 - Global Pharmaceutical Linkage Regulations: A Proposed Analytical Framework
May-04-2011 - Life Sciences Handbook 2011 – Country Q&A
Mar-25-2011 - Supreme Court upholds the worth of formulation patents
Jul-27-2010 - Pharmaceutical Trademarks 2009
Jun-11-2010 - Pharmaceutical Advertising 2008
Jun-11-2010 - Framework for biotherapeutic products established
Jun-09-2010 - Repercussions expected on medicine advertising campaign in Mexico
May-28-2010 - Drugs Patent Reforms Introduced
Apr-01-2004